Blueprint vs Emosapien

Depends on the job. Blueprint is a measurement-based-care platform: a deep pre-built catalog of validated assessments (PHQ-9, GAD-7 plus niche measures like AUDIT, EDE-Q, Y-BOCS and BSL-23), auto-scoring, outcomes dashboards, and payer-ready reporting. Emosapien is AI co-therapy: a Co-Therapy Agent that participates during the session with modality-aligned prompts, an Engagement Agent that runs the week between sessions, AI-drafted progress notes, and treatment-plan automation. It also auto-scores a full outcome-measure library (PHQ-9, GAD-7, ORS, SRS, DASS-21 and WHOQOL-BREF as standard, plus PCL-5, OQ-45 and custom scales on Pro/Enterprise). Pick Blueprint for pre-built niche-assessment breadth and payer-ready reporting. Pick Emosapien for AI inside the session and across the full week with MBC built in.

No. Blueprint is built around measurement-based care: assessments delivered to clients between sessions, scored automatically, plotted against trends in the clinician dashboard. The clinician runs the session itself unaided by Blueprint. Emosapien is built differently: the Co-Therapy Agent listens during the session and surfaces modality-aligned cues (CBT reframes, ACT values prompts, DBT distress-tolerance moves) tied to the active treatment goal, and the progress note is drafted from that clinical context.

Yes for the core MBC program. The Engagement Agent auto-schedules and scores PHQ-9, GAD-7, ORS, SRS, DASS-21 and WHOQOL-BREF as standard, plus PCL-5, OQ-45 and custom scales on Professional and Enterprise, and plots trends against the treatment-plan objective and surfaces the change in the pre-session brief. Blueprint covers a wider pre-built niche-assessment catalog (AUDIT, EDE-Q, Y-BOCS, BSL-23 and more) and offers deeper payer-ready outcomes reporting for value-based contracts. If your MBC program depends on that breadth of niche measures or payer-ready reporting, Blueprint stays the stronger pure-measurement tool; if a full core library plus continuous client engagement is enough, Emosapien covers it natively. The practical MBC guide walks through what a working program looks like.

Three structural things. (1) Active in-session co-therapy: the Co-Therapy Agent participates during the session with modality-aligned intervention prompts, not just assessment scores between sessions. (2) AI-drafted progress notes: SOAP, DAP, BIRP, GIRP, PIE drafted from the session, not a separate documentation workflow. (3) Treatment-plan automation: a structured plan with SMART objectives that updates from session notes automatically. Blueprint is a measurement-based-care platform; these are different jobs.

Emosapien is publicly priced: Free (10 sessions per month, no credit card), Starter ($29/seat/month annual), Professional ($79/seat/month annual, includes the Co-Therapy and Engagement Agents), Enterprise (custom). Blueprint pricing has historically been quote-driven for groups and requires a conversation with their sales team for current numbers; their solo-clinician tier is publicly priced. Verify current Blueprint pricing directly on their website before committing. See Emosapien pricing for full plan limits.

Yes, and some practices do. Blueprint handles deep MBC and payer reporting; Emosapien handles in-session co-therapy, progress notes, treatment-plan automation, and between-session client engagement. They overlap on PHQ-9 / GAD-7 / ORS scheduling, so pick one place to run those measures to avoid duplicate delivery to clients. Most practices that evaluate Emosapien after Blueprint do so because they want AI inside the session or want to consolidate the between-session client surface into one app.